BackX.T.L. Biopharmaceuticals Overview

X.T.L. Biopharmaceuticals Current Cash

Latest current cash for XTLB: $76K.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$76000.00
↓ 79.51% YoYΔ $-295000.00 vs prior year quarter

Peer average

Loading

X.T.L. Biopharmaceuticals Current Cash History

Loading

X.T.L. Biopharmaceuticals vs. peers: Current Cash Comparison

Loading

X.T.L. Biopharmaceuticals Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

X.T.L. Biopharmaceuticals (XTLB) FAQ

X.T.L. Biopharmaceuticals (XTLB) currently reports a current cash of $76K as of December 2025. That compares with $370K in the prior-year period — down 79.5% year over year. Use the charts on this page to explore X.T.L. Biopharmaceuticals's current cash history and peer comparisons.

X.T.L. Biopharmaceuticals's current cash decreased from $370K to $76K — a 79.5% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

X.T.L. Biopharmaceuticals reported $76K in current cash as of December 2025. That compares with $370K in the prior-year period — down 79.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $76K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for X.T.L. Biopharmaceuticals, and consider following XTLB for alerts when major investors trade the stock.

X.T.L. Biopharmaceuticals is classified in the Healthcare sector. On current cash, it currently shows $76K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing XTLB with unrelated industries.